Literature DB >> 9382968

Splanchnic and extrasplanchnic arterial hemodynamics in patients with cirrhosis.

T Iwao1, K Oho, T Sakai, C Tayama, M Sato, R Nakano, M Yamawaki, A Toyonaga, K Tanikawa.   

Abstract

BACKGROUND/AIMS: This study was designed to assess the contribution of splanchnic and extrasplanchnic vascular hemodynamics to the hyperdynamic circulation in patients with cirrhosis.
METHODS: Cardiac index and flow volume index and pulsatility index (PI) of superior mesenteric artery (SMA) and femoral artery (FA) were measured with Doppler ultrasonography in 40 controls and 86 patients with cirrhosis (Child-Pugh grade A=41, grade B=30, and grade C=15). Mean arterial pressure was also recorded to calculate systemic vascular resistance index.
RESULTS: Systemic vascular resistance index was significantly lower in each Child-Pugh group than in controls. SMA blood flow index was significantly higher in each Child-Pugh group than in controls and the increase in SMA blood flow index paralleled the degree of liver dysfunction. SMA-PI was significantly lower in each Child-Pugh group than in controls and the decrease in SMA-PI paralleled the degree of liver dysfunction. FA blood flow index was slightly higher in Child-Pugh grade A patients and significantly higher in grade B patients than in controls, whereas grade C patients had normal FA blood flow index. FA-PI was significantly lower in grade A and grade B patients than in controls, whereas grade C patients had normal FA-PI. When all patients were examined together, SMA-PI significantly correlated with systemic vascular resistance index (r=0.69, p<0.01). In contrast, FA-PI did not significantly correlate with systemic vascular resistance index (r=0.15, p=0.18).
CONCLUSIONS: Splanchnic arterial vasodilatation plays an important role in the pathogenesis of decreased systemic vascular resistance seen in patients with cirrhosis.

Entities:  

Mesh:

Year:  1997        PMID: 9382968     DOI: 10.1016/s0168-8278(97)80318-2

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  7 in total

1.  A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance.

Authors:  Trevor N Johnson; Koen Boussery; Karen Rowland-Yeo; Geoffrey T Tucker; Amin Rostami-Hodjegan
Journal:  Clin Pharmacokinet       Date:  2010-03       Impact factor: 6.447

Review 2.  Terlipressin and hepatorenal syndrome: what is important for nephrologists and hepatologists.

Authors:  Ahmed A Magan; Atif A Khalil; Mohamed H Ahmed
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

3.  Effect of meal induced splanchnic arterial vasodilatation on renal arterial haemodynamics in normal subjects and patients with cirrhosis.

Authors:  T Iwao; K Oho; R Nakano; M Yamawaki; T Sakai; M Sato; Y Miyamoto; A Toyonaga; K Tanikawa
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

4.  Vascular Doppler ultrasonographic indices in cirrhosis: a case-control study with emphasis on the common carotid arteries.

Authors:  Abolhassan Shakeri; Mojtaba Varshochi; Naser Atapour; Masoud Nemati; Manoochehr Khoshbaten; Daniel Fadaei Fouladi
Journal:  Radiol Med       Date:  2015-03-01       Impact factor: 3.469

Review 5.  Management of hepatorenal syndrome.

Authors:  Halit Ziya Dundar; Tuncay Yılmazlar
Journal:  World J Nephrol       Date:  2015-05-06

6.  Radiofrequency ablation for hypersplenism in patients with liver cirrhosis: a pilot study.

Authors:  Quanda Liu; Kuansheng Ma; Zhenping He; Jiahong Dong; Xin Hua; Xuequan Huang; Liang Qiao
Journal:  J Gastrointest Surg       Date:  2005 May-Jun       Impact factor: 3.452

7.  A new method for diagnosis of cirrhosis disease: complex-valued artificial neural network.

Authors:  Yüksel Ozbay
Journal:  J Med Syst       Date:  2008-10       Impact factor: 4.460

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.